The division, which previously operating as Morgan Sindall Professional Services (MSPS) in Switzerland, Austria and Germany, has been rebranded BakerHicks as part of a new strategy to deliver an integrated service to UK and European Life Sciences clients.
Remaining part of the Morgan Sindall Group, the now combined BakerHicks Life Sciences operation pools the engineering consultancy and pharmabio capabilities of its European team with the project delivery and fill finish skills of its UK operation. This will enable BakerHicks’ pharmaceutical and Life Sciences clients to leverage the company’s wider European locations and subject matter expertise.
Mark Dickson, the new managing director for BakerHicks’ Life Sciences and Industry sector, says:
"Life Sciences is a significant and growing part of our business, and by coming together to operate as a single business we can deliver a complete solution for our clients, from consultancy projects and embedded engineers, through to the management and delivery of major capital programmes.
"Although we are a sizeable business, we operate with the agility of a smaller firm, adapting our services and tailoring our approach on a client-by-client basis."
Martin Lubieniecki, BakerHicks managing director, adds:
"It will enable the business to share resources, ideas and best practice.
"Our people are still at the heart of our delivery, and with common processes, systems and management we will be able to deliver a consistent, world-class service to meet the current and future needs of our Life Sciences clients."
Following the restructuring, the company expects to announce several new senior appointments during the coming months.